ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,456, issued on Dec. 16, was assigned to SHANGHAI JMT-BIO TECHNOLOGY Co. LTD. (Shanghai).
"Bispecific recombinant protein and use thereof" was invented by Liping Song (Shanghai), Xiaotian Cui (Shanghai), Jian Wang (Shanghai), Haixiang Wu (Shanghai), Jiana Jia (Shanghai), Yi Fan (Shanghai), Ganliang Zhang (Shanghai), Tao Li (Shanghai), Hong Xu (Shanghai), Yisha She (Shanghai) and Kai Long (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a bispecific recombinant protein, comprising a high affinity tumor-targeting arm and a low affinity fusion protein blocking the interaction of CD47 with SIRPAlpha. The antibody corresponding to the ...